dr. Kenny Roose
Show
Sort by
-
- Journal Article
- A1
- open access
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A
-
Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice
-
Hepatitis B core-based virus-like particles to present heterologous epitopes
-
- PhD Thesis
- open access
Design and validation of novel cross-reactive influenza B vaccines
(2012) -
Cutting edge approaches towards novel and cross-protective influenza vaccines
-
- Journal Article
- A1
- open access
A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection
-
- Journal Article
- A1
- open access
Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective
-
M2e-based universal influenza A vaccine
-
PANDEMIC PREPAREDNESS: TOWARD A UNIVERSAL INFLUENZA VACCINE
-
Vaccine development by recombinant DNA technology. Part II: Virus-like Particles
-
Vaccine development by recombinant DNA technology. Part I: DNA Vaccines
-
An influenza A vaccine based on tetrameric ectodomain of matrix protein 2